These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7673610)
1. Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole shown in vitro. Mégraud F J Clin Gastroenterol; 1995; 20 Suppl 1():S24-7. PubMed ID: 7673610 [TBL] [Abstract][Full Text] [Related]
2. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication. Kawano S; Murakami M; Saita H; Tsuji S J Gastroenterol; 1996 Nov; 31 Suppl 9():41-3. PubMed ID: 8959517 [TBL] [Abstract][Full Text] [Related]
3. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer]. Kayser S; Flury R; Zbinden R; Fried M; Wirth HP Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483 [TBL] [Abstract][Full Text] [Related]
4. Effect of lansoprazole on Helicobacter pylori. Lamouliatte H Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593 [TBL] [Abstract][Full Text] [Related]
5. [Lansoprazole: a review of its role in Helicobacter pylori eradication therapy]. Gisbert JP Rev Esp Enferm Dig; 1999 Feb; 91(2):133-43. PubMed ID: 10231305 [TBL] [Abstract][Full Text] [Related]
6. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study. Gupta VK; Dhar A; Srinivasan S; Rattan A; Sharma MP Am J Gastroenterol; 1997 Jul; 92(7):1140-2. PubMed ID: 9219786 [TBL] [Abstract][Full Text] [Related]
7. [Helicobacter pylori eradication: modified triple therapy with lansoprazole]. Müller P; Simon B Fortschr Med; 1996 Dec; 114(35-36):497-9. PubMed ID: 9119351 [TBL] [Abstract][Full Text] [Related]
8. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol. Ushiama H; Echizen H; Nachi S; Ohnishi A Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002 [TBL] [Abstract][Full Text] [Related]
9. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
10. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence. Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995 [TBL] [Abstract][Full Text] [Related]
11. [Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy]. Tamura K; Murai M; Tanaka M; Kawano S Nihon Rinsho; 1993 Dec; 51(12):3261-6. PubMed ID: 8283644 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. Lamouliatte H; Perie F; Joubert-Collin M Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736 [TBL] [Abstract][Full Text] [Related]
13. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients. Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449 [TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro. Vogt K; Hahn H Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430 [TBL] [Abstract][Full Text] [Related]
15. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons]. Holtmann G; Layer P; Goebell H Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357 [TBL] [Abstract][Full Text] [Related]
17. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. Sullivan B; Coyle W; Nemec R; Dunteman T Am J Gastroenterol; 2002 Oct; 97(10):2536-9. PubMed ID: 12385435 [TBL] [Abstract][Full Text] [Related]
18. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514 [TBL] [Abstract][Full Text] [Related]
19. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study. Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413 [TBL] [Abstract][Full Text] [Related]
20. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]